At Manningham Medical Centre, you can find all the data about Pelias Biomedical Development Ag. We have collected data about general practitioners, medical and surgical specialists, dental, pharmacy and more. Please see the links below for the information you need.


Intercell completes acquisition of Pelias - bionity.com

    https://www.bionity.com/en/news/60851/intercell-completes-acquisition-of-pelias.html
    Intercell AG announced that the acquisition of Pelias Biomedical Development AG, Vienna (Austria) was completed with a capital increase. 349.815 new shares, which represent about 0.9 percent of In ...

Pelias Biomedical Development AG - Company Profiles - BCIQ

    https://profiles.biocentury.com/companies/pelias
    For the biopharma industry investment, business development and competitive intelligence professionals who require information to support financing, …

Intercell announces intention to acquire Pelias AG to strengthen …

    https://www.bionity.com/en/news/59976/intercell-announces-intention-to-acquire-pelias-ag-to-strengthen-its-product-portfolio-and-strategic-focus.html
    Pelias develops products and holds certain licenses in the field of vaccines against important pathogens involved in hospital-acquired infections, including a clinical stage …

Intercell to acquire remainder of Pelias - Pharmaceutical …

    https://www.thepharmaletter.com/article/intercell-to-acquire-remainder-of-pelias
    Intercell to acquire remainder of Pelias. intercell, acquire, remainder, pelias, germany, ag, agreed

New Biotech Startup, Pelias AG To Fight Hospital Infections

    https://www.biospace.com/article/releases/new-biotech-startup-pelias-ag-to-fight-hospital-infections-/
    The foundation of Pelias is based on a strong global partnership between Intercell and Parteurop, who joined forces to build up a new biotech company by …

Pelias Biomedical Development AG Company Profile, Financial …

    https://digitgaps.com/report-store/pelias-biomedical-development-ag-company-profile-financial-and-strategic-swot-analysis-mergers-and-acquisitions-partnerships-and-investments-news-key-profiles-and-competitors-report/
    digitGaps report on Pelias Biomedical Development AG delivers a detailed in-depth and comprehensive insights of the company, its history, corporate strategy, its businesses …

Pelias Biomedizinische Entwicklungs AG Company Profile, …

    https://digitgaps.com/report-store/pelias-biomedizinische-entwicklungs-ag-company-profile-financial-and-strategic-swot-analysis-mergers-and-acquisitions-partnerships-and-investments-news-key-profiles-and-competitors-report/
    As of January 2, 2007, Pelias Biomedizinische Entwicklungs AG is a subsidiary of Intercell Biomedical Research & Development AG. digitGaps report on Pelias …

BioCentury - caprotec management update

    https://www-biocentury-com.proxy.lib.umich.edu/article/178152/caprotec-management-update
    caprotec bioanalytics GmbH, Berlin, Germany Business: Proteomics, Supply/Service Hired: Mathias Grote as CFO and COO, former CEO of Pelias …

Intercell completes acquisition of Pelias | 15.01.2007

    https://www.ots.at/presseaussendung/OTE_20070115_OTE0002/intercell-completes-acquisition-of-pelias
    Intercell completes acquisition of Pelias. Wien (euro adhoc)-ots.CorporateNews transmitted by euro adhoc. The issuer is responsible for the content …

euro adhoc: Intercell AG / Mergers - Acquisitions - Takeovers ...

    https://www.presseportal.ch/de/pm/100005032/100521036
    » Vienna-based Pelias AG focuses on the development of novel vaccines against hospital-acquired infections - the company s lead product, a novel protein based …



Need more information about Pelias Biomedical Development Ag?

At Manningham Medical Centre, we collected data on more than just Pelias Biomedical Development Ag. There is a lot of other useful information. Visit the related pages or our most popular pages. Also check out our Doctors page.